Having trouble accessing articles? Reset your cache.

NovaDel, Suda deal

NovaDel will sell its NovaMist sublingual delivery technology along with other assets to Suda for an upfront payment of $400,000 plus 50 million shares of Suda

Read the full 267 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE